We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

292 hedge funds and large institutions have $10.9B invested in Alnylam Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 83 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 34

37% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 83

4% more funds holding

Funds holding: 282 → 292 (+10)

3% more call options, than puts

Call options by funds: $109M | Put options by funds: $105M

2.24% less ownership

Funds ownership: 93.75% → 91.51% (-2.2%)

7% less capital invested

Capital invested by funds: $11.7B → $10.9B (-$792M)

14% less funds holding in top 10

Funds holding in top 10: 14 → 12 (-2)

Holders
292
Holders Change
+10
Holders Change %
+3.55%
% of All Funds
6.69%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.28%
New
47
Increased
114
Reduced
83
Closed
34
Calls
$109M
Puts
$105M
Net Calls
+$3.5M
Net Calls Change
-$17.1M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$106M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$54.2M
3
FCM
Farallon Capital Management
California
+$47.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$43.3M
5
O
OrbiMed
New York
+$41.8M

Top Sellers

1
Dodge & Cox
Dodge & Cox
California
-$456M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$35.2M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$29.4M
4
Goldman Sachs
Goldman Sachs
New York
-$22.8M
5
LCM
Laurion Capital Management
New York
-$15.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
OPPM
151
Opus Point Partners Management
New York
$1.63M -$3.79M -29,384 -68%
Comerica Bank
152
Comerica Bank
Texas
$1.55M -$6.06K -47 -0.3%
SAM
153
Shell Asset Management
Netherlands
$1.42M -$1.53M -11,849 -50%
Mitsubishi UFJ Asset Management
154
Mitsubishi UFJ Asset Management
Japan
$1.4M -$86.8K -673 -5%
SM
155
Sabby Management
Florida
$1.37M -$999K -7,750 -40%
NAM
156
Nissay Asset Management
Japan
$1.37M +$20.6K +160 +1%
AIM
157
ARK Investment Management
Florida
$1.32M +$1.16M +9,014 +430%
Nomura Asset Management
158
Nomura Asset Management
Japan
$1.28M – – –
Skandinaviska Enskilda Banken (SEB)
159
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.26M -$739K -5,730 -35%
SIM
160
Spark Investment Management
New York
$1.25M +$1.35M +10,500 New
DZ Bank
161
DZ Bank
Germany
$1.15M +$1.24M +9,650 New
VF
162
Virtu Financial
New York
$1.13M +$1.22M +9,472 New
Korea Investment Corp
163
Korea Investment Corp
South Korea
$1.11M +$1.2M +9,302 New
Treasurer of the State of North Carolina
164
Treasurer of the State of North Carolina
North Carolina
$1.1M +$1.19M +9,246 New
Jane Street
165
Jane Street
New York
$1.1M +$772K +5,987 +184%
APG Asset Management
166
APG Asset Management
Netherlands
$1.09M +$193K +1,500 +15%
PNC Financial Services Group
167
PNC Financial Services Group
Pennsylvania
$1.05M -$2.06K -16 -0.2%
NIMI
168
Natixis Investment Managers International
France
$1.01M +$487K +3,777 +80%
LWCFA
169
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$956K – – –
SOADOR
170
State of Alaska Department of Revenue
Alaska
$936K +$202K +1,570 +25%
KBC Group
171
KBC Group
Belgium
$921K +$8.38K +65 +0.8%
AWM
172
Aevitas Wealth Management
Massachusetts
$899K -$38.7K -300 -4%
AIM
173
Achmea Investment Management
Netherlands
$880K – – –
TAF
174
Tredje AP-fonden
Sweden
$858K +$458K +3,550 +97%
GCA
175
Gideon Capital Advisors
New York
$832K +$901K +6,985 New
5 6
7
8 9

ALNY Hedge Fund Activity: Q1 2018 in Review

292 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2018, worth a combined $10.9B — down 6.8% from $11.7B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ALNY positions and 34 closed out — a net gain of 13 holders — while 114 added to existing stakes and 83 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $106M. The largest seller was Dodge & Cox, cutting an estimated $456M.

  • 292 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2018, up from 282 in Q4 2017.
  • Funds reported $10.9B of Alnylam Pharmaceuticals stock for Q1 2018, down 6.8% quarter-over-quarter.
  • 47 funds opened new Alnylam Pharmaceuticals positions in Q1 2018 and 34 closed out, a net change of +13 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2018 was Point72 Asset Management, an estimated $106M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2018 was Dodge & Cox, an estimated $456M sold.

Based on aggregated 13F filings for Q1 2018.